AUD 1.18
(5.83%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -4.7 Million AUD | 28.9% |
2022 | -6.61 Million AUD | -31.18% |
2021 | -5.04 Million AUD | 16.6% |
2020 | -6.04 Million AUD | -107.51% |
2019 | -2.91 Million AUD | -8114.24% |
2018 | -35.45 Thousand AUD | 97.67% |
2017 | -1.52 Million AUD | -271.04% |
2016 | 891.36 Thousand AUD | -81.4% |
2015 | 4.79 Million AUD | 17.89% |
2014 | 4.06 Million AUD | 621.26% |
2013 | -779.95 Thousand AUD | 25.3% |
2012 | -1.04 Million AUD | -9.19% |
2011 | -956.22 Thousand AUD | -312.44% |
2010 | 450.1 Thousand AUD | -77.98% |
2009 | 2.04 Million AUD | 16.36% |
2008 | 1.75 Million AUD | 55.32% |
2007 | 1.13 Million AUD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -7.5 Million AUD | 0.0% |
2023 Q4 | -1.8 Million AUD | 0.0% |
2023 FY | -4.7 Million AUD | 28.9% |
2023 Q2 | -2.89 Million AUD | 0.0% |
2022 Q2 | -2.56 Million AUD | 0.0% |
2022 Q4 | -4.04 Million AUD | 0.0% |
2022 FY | -6.61 Million AUD | -31.18% |
2021 Q2 | -3.92 Million AUD | 0.0% |
2021 Q4 | -1.11 Million AUD | 0.0% |
2021 FY | -5.04 Million AUD | 16.6% |
2020 FY | -6.04 Million AUD | -107.51% |
2020 Q4 | -393.75 Thousand AUD | 0.0% |
2020 Q2 | -5.64 Million AUD | 0.0% |
2019 FY | -2.91 Million AUD | -8114.24% |
2019 Q4 | 112.07 Thousand AUD | 0.0% |
2019 Q2 | -3.02 Million AUD | 0.0% |
2018 Q4 | 649.23 Thousand AUD | 0.0% |
2018 FY | -35.45 Thousand AUD | 97.67% |
2018 Q2 | -684.68 Thousand AUD | 0.0% |
2017 Q4 | -97.45 Thousand AUD | 0.0% |
2017 FY | -1.52 Million AUD | -271.04% |
2017 Q2 | -1.42 Million AUD | 0.0% |
2016 Q2 | 283.61 Thousand AUD | 0.0% |
2016 Q4 | 607.75 Thousand AUD | 0.0% |
2016 FY | 891.36 Thousand AUD | -81.4% |
2015 Q4 | 4.61 Million AUD | 0.0% |
2015 FY | 4.79 Million AUD | 17.89% |
2015 Q2 | 178.84 Thousand AUD | 0.0% |
2014 Q2 | 923.41 Thousand AUD | 0.0% |
2014 FY | 4.06 Million AUD | 621.26% |
2014 Q4 | 3.14 Million AUD | 0.0% |
2013 Q4 | -8.99 Million AUD | 0.0% |
2013 FY | -779.95 Thousand AUD | 25.3% |
2013 Q2 | -1.12 Million AUD | 53.23% |
2013 Q1 | -2.41 Million AUD | 0.0% |
2012 Q1 | -261.03 Thousand AUD | 0.0% |
2012 Q2 | -261.03 Thousand AUD | 0.0% |
2012 Q3 | -261.03 Thousand AUD | 0.0% |
2012 FY | -1.04 Million AUD | -9.19% |
2012 Q4 | -2.41 Million AUD | -823.27% |
2011 Q3 | -239.05 Thousand AUD | 0.0% |
2011 FY | -956.22 Thousand AUD | -312.44% |
2011 Q4 | -261.03 Thousand AUD | -9.19% |
2011 Q1 | -239.05 Thousand AUD | 0.0% |
2011 Q2 | -239.05 Thousand AUD | 0.0% |
2010 Q1 | 112.52 Thousand AUD | 0.0% |
2010 FY | 450.1 Thousand AUD | -77.98% |
2010 Q4 | -239.05 Thousand AUD | -312.44% |
2010 Q3 | 112.52 Thousand AUD | 0.0% |
2010 Q2 | 112.52 Thousand AUD | 0.0% |
2009 Q3 | 511.12 Thousand AUD | 0.0% |
2009 Q4 | 112.52 Thousand AUD | -77.98% |
2009 FY | 2.04 Million AUD | 16.36% |
2009 Q1 | 511.12 Thousand AUD | 0.0% |
2009 Q2 | 511.12 Thousand AUD | 0.0% |
2008 Q3 | 439.26 Thousand AUD | 0.0% |
2008 Q2 | 439.26 Thousand AUD | 0.0% |
2008 Q1 | 439.26 Thousand AUD | 0.0% |
2008 FY | 1.75 Million AUD | 55.32% |
2008 Q4 | 511.12 Thousand AUD | 16.36% |
2007 Q4 | 439.26 Thousand AUD | 55.32% |
2007 Q1 | 282.8 Thousand AUD | 0.0% |
2007 Q3 | 282.8 Thousand AUD | 0.0% |
2007 Q2 | 282.8 Thousand AUD | 0.0% |
2007 FY | 1.13 Million AUD | 0.0% |
2006 Q4 | 282.8 Thousand AUD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
4DMedical Limited | -35.97 Million AUD | 86.934% |
Adherium Limited | -10.22 Million AUD | 54.023% |
Aroa Biosurgery Limited | -9.74 Million AUD | 51.778% |
Atomo Diagnostics Limited | -6.84 Million AUD | 31.353% |
Anteris Technologies Ltd | -67.33 Million AUD | 93.019% |
Control Bionics Limited | -5.91 Million AUD | 20.511% |
CardieX Limited | -6.76 Million AUD | 30.517% |
Compumedics Limited | -338 Thousand AUD | -1290.771% |
Cochlear Limited | 356.8 Million AUD | 101.317% |
CleanSpace Holdings Limited | -3.12 Million AUD | -50.323% |
EMVision Medical Devices Ltd | -2.72 Million AUD | -72.215% |
Nova Eye Medical Limited | -8.79 Million AUD | 46.521% |
HeraMED Limited | -6.78 Million AUD | 30.704% |
Imricor Medical Systems, Inc. | -22.62 Million AUD | 79.224% |
ImpediMed Limited | -19.79 Million AUD | 76.247% |
InhaleRx Limited | -1.44 Million AUD | -225.705% |
LBT Innovations Limited | -3.74 Million AUD | -25.69% |
Micro-X Limited | -9.76 Million AUD | 51.861% |
Neurotech International Limited | -5.06 Million AUD | 7.268% |
OncoSil Medical Limited | -11.91 Million AUD | 60.543% |
PolyNovo Limited | 5.26 Million AUD | 189.352% |
Respiri Limited | -7.12 Million AUD | 34.063% |
SomnoMed Limited | -12.24 Million AUD | 61.6% |
Universal Biosensors, Inc. | -6.74 Million AUD | 30.271% |
Uscom Limited | -2.07 Million AUD | -126.572% |
Visioneering Technologies, Inc. | -5.06 Million AUD | 7.159% |